Atherosclerosis, Degenerative Aortic Stenosis and Statins

Current Drug Targets

Volumn 12, Issue 1, 2011, Pages 115-121

  Novo, Giuseppina ^a   Fazio, Giovanni ^a   Visconti, Claudia ^a   Carità, Patrizia ^a   Maira, Ermanno ^a   Fattouch, Khalil ^a   Novo, Salvatore ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Aortic stenosis; Atherosclerosis; Statin

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DRUG INDICATION; HUMAN; HYPERLIPIDEMIA; PATHOGENESIS; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANIMALS; AORTIC VALVE STENOSIS; ATHEROSCLEROSIS; EVIDENCE-BASED MEDICINE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;

EID: 78650902698     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/138945011793591545     Document Type: Article

References (40)

1. Lindroos ML, Kupari M, Heikkila J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 1993; 21: 1220-5.
2. Antonini-Canterin F, Nicolosi GL. La progressione emodinamica della stenosi valvolare aortica nell'adulto: implicazioni per la gestione clinica del paziente asintomatico. Ital Heart J Suppl 2002; 3: 478-5.
3. Iivanainen AM, Lindroos M, Tilvis R, Heikkila J, Kupari M. Natural history of aortic valve stenosis of varying severity in the elderly. Am J Cardiol 1996; 78: 97-101.
4. Otto CM, Burwash IG, Legget ME, et al. Prospective study of asymptomatic valvular aortic stenosis: clinical, echocardiographic, and exercise predictors of outcome. Circulation 1997; 95: 2262-70.
5. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997; 3: 630-4.
6. Wierzbicki A, Shetty C. Aortic stenosis: an atherosclerotic disease? J Heart Valve Dis 1999; 8: 416-23.
7. Chui MC, Newby DE, Panarelli M, Bloomfield P, Boon NA. Association between calcific aortic stenosis and hypercholestero-lemia: is there a need for a randomized controlled trial of cholesterol-lowering therapy? Clin Cardiol 2001; 24: 52-5.
8. Otto CM, O'Brien KD. Why is there discordance between calcific aortic stenosis and coronary artery disease? Heart 2001; 85: 601-2.
9. Otto CM, Knusisto J, Reichenbach D, Gown AM, O'Brien KD. Characterization of the early lesion of degenerative valvular aortic stenosis; Historical and immunohistochemical studies. Circulation 1994; 90: 844-53.
10. Demer LL. A skeleton in the atherosclerosis closet. Circulation 1995; 92: 2029-32.
11. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999; 341: 142-7.
12. Lindroos M, Kupari M, Valvanne J, et al. Factors associated with calcific aortic valve degeneration in the elderly. Eur Heart J 1994; 15: 865-70.
13. Agmon Y, Khandheria BK, Meissner I, et al. Aortic valve sclerosis and aortic atherosclerosis: different manifestations of the same disease? Insights from a population-based study. J Am Coll Cardiol 2001; 38: 827-34.
14. Aronow WS, Schwartz KS, Koenigsberg M. Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients. Am J Cardiol 1987; 59: 998-9.
15. Leggett M, Otto CM. Aortic valve disease. Curr Opin Cardiol 1996; 11: 120-5.
16. Sprecher DL, Schaefer EJ, Kent KM, et al. Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patients. Am J Cardiol 1984; 54: 20-30.
17. Brook GJ, Keidar S, Boulos M, et al. Familial homozygous hypercholesterolemia: clinical and cardiovascular features in 18 patients. Clin Cardiol 1989; 12: 333-8.
18. Sarphie TG. Surface responses of aortic valve endothelia from diet-induced, hypercholesterolemic rabbits. Atherosclerosis 1985; 54: 283-99.
19. Rajamannan NM, Sangiorgi G, Springett M, et al. Experimental hypercholesterolemia induces apoptosis in the aortic valve. J Heart Valve Dis 2001; 10: 371-4.
20. Agmon Y, Khandheria BK, Meissner I, et al. Aortic valve sclerosis and aortic atherosclerosis: different manifestations of the same disease? Insights from a population-based study. J Am Coll Cardiol 2001; 38: 827-34.
21. Keller C, Schmitz H, Theisen K, Zollner N. Regression of valvular aortic stenosis due to homozygous familial hypercholesterolemia following plasmapheresis. Klin Wochenschr 1986; 64: 338-41.
22. Rajamannan NM, Subramaniam M, Springett M, et al. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation 2002; 105: 2660-5.
23. Novaro GM, Tiong IY, Pearce GL, Lauer MS, Sprecher DL, Griffin BP. Effect of hydroxymethylglutaryl coenzyme A reductase inhibitors on the progression of calcific aortic stenosis. Circulation 2001; 104: 2205-9.
24. Aronow WS, Ahn C, Kronzon I, Goldman ME. Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am J Cardiol 2001; 88: 693-5.
25. Pohle K, Maffert R, Ropers D, et al. Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors. Circulation 2001; 104: 1927-32.
26. Shavelle DM, Takasu J, Budoff MJ, Mao S, Zhao XQ, O'Brien KD. HMG CoA reductase inhibitor (statin) and aortic valve calcium. Lancet 2002; 359: 1125-6.
27. Bellamy MF, Pellikka PA, Klarich KW, Tajik AJ, Enriquez-Sarano M. Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. J Am Coll Cardiol 2002; 40: 1723-30.
28. Rosenhek R, Rader F, Loho N, et al. Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis. Circulation 2004; 110: 1291-5.
29. Balk EM, Karas RH, Jordan HS, Kupelnick B, Chew P, Lau J. Effects of statins on vascular structure and function: a systematic review. Am J Med 2004; 117: 775-90.
30. Antonini-Canterin F, Hîrşu M, Popescu BA, et al. Stage-related effect of statin treatment on the progression of aortic valve sclerosis and stenosis. Am J Cardiol 2008; 102: 738-42.
31. Cowell J, Newly D, Prescott RJ, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis (SALTIRE). N Engl J Med 2005; 352: 2389-97.
32. Moura LM, Ramos SF, Zamorano JL, et al. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. JACC 2007; 49: 562-64.
33. Rossebø AB, Pedersen TR, Boman K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 2008; 359: 1343-56.
34. Smilde TJ, van Wissen S, Awollersheim H, Trip MD, Kastelein JJP, Stalenhoef AFH. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholes-terolemia (ASAP): a prospective, randomised, double-blind trial. Lancet 2001; 357: 577-58.
35. Kastelein JJ, Akdim F, Stroes ESG, et al. Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia. N Engl J Med 2008; 358: 1431-43.
36. Chan KL, Teo K, Tam J, Dumesnil JG, Ni A, Tam J for the astronomer investigators. Effect of lipid lowering with rosuvastatin on progression of aortic stenosis results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation 2010; 121: 306-14.
37. McCullough PA, Rocher LR. Statin therapy in renal disease: harmful or protective? Curr Atheroscler Rep 2007; 9: 18-24.
38. Randomized study to evaluate the efficacy of fluvastatin on inflammatory markers in the haemodynamic progression of degenerative aortic stenosis. Available at: http://www.clinical-trials.gov/ct2/show/NCT00404287 (accessed at February 02, 2008).
39. Statin therapy in asymptomatic aortic stenosis. Available at: http://www.clinicaltrials.gov/ct2/show/NCT00176410 (accessed February 02, 2008).
40. The effect of statin therapy (Atorvastatin) on the progression of calcific valvular aortic stenosis (STOP-AS). Available at: http://www.clinicaltrials.gov/ct2/show/NCT00590135 (accessed February 02, 2008).